FC
RVMD icon

FORA Capital’s Revolution Medicines RVMD Stock Holding History

FORA Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$818K Sell
4,368
-10,850
-71% -$1.58M 0.06% 232
2026
Q1 		$1.48M Sell
15,218
-2,139
-12% -$216K 0.11% 192
2025
Q4 		$1.37M Buy
17,357
+10,988
+173% +$720K 0.17% 163
2025
Q3 		$297K Buy
+6,369
New +$249K 0.05% 373
2021
Q3 		– Sell
-2,581
Closed -$82K – 773
2021
Q2 		$82K Buy
+2,581
New +$90.1K 0.02% 632
2021
Q1 		– Sell
-4,488
Closed -$178K – 1050
2020
Q4 		$178K Buy
+4,488
New +$177K 0.03% 536

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

FORA Capital's RVMD Position: Q2 2026 in Review

FORA Capital reduced its Revolution Medicines (RVMD) stake by 71% in Q2 2026, selling an estimated $1.58M and leaving 4,368 shares worth $818K. The position accounts for 0.06% of the portfolio, ranked #232.

FORA Capital first reported a position in RVMD in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.48M in Q1 2026. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • FORA Capital held 4,368 shares of Revolution Medicines worth $818K as of Q2 2026.
  • FORA Capital sold 10,850 Revolution Medicines shares in Q2 2026, an estimated $1.58M.
  • Revolution Medicines made up 0.06% of FORA Capital's portfolio in Q2 2026, its #232 holding.
  • FORA Capital first reported a position in Revolution Medicines in Q4 2020 and has held it in 6 quarters since.
  • FORA Capital's Revolution Medicines position peaked at $1.48M in Q1 2026.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.